Brad Sherborne

Title: Brad Sherborne: Innovator in Pharmaceutical Chemistry

Introduction

Brad Sherborne is a notable inventor based in Auchterarder, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aminopyrimidine derivatives. His research focuses on developing new therapeutic agents for a variety of diseases.

Latest Patents

Brad Sherborne holds a patent for "Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases." This invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof. The patent outlines their use as pharmaceutically active agents for the prophylaxis and treatment of infectious diseases, autoimmune diseases, cardiovascular diseases, and more. The invention also discusses the use of these derivatives as inhibitors for protein kinases, which are crucial in various biological processes.

Career Highlights

Throughout his career, Brad has worked with prominent organizations in the pharmaceutical industry. He has been associated with Lead Discovery Center GmbH and Bayer Pharma Aktiengesellschaft, where he has contributed to various research projects and innovations. His work has been instrumental in advancing the understanding of drug development and therapeutic applications.

Collaborations

Brad Sherborne has collaborated with notable professionals in his field, including Axel Choidas and Alexander Backes. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

Brad Sherborne's contributions to pharmaceutical chemistry, particularly through his patent on aminopyrimidine derivatives, highlight his role as an innovator in the field. His work continues to pave the way for new treatments for various diseases, showcasing the importance of innovation in healthcare.